The relevance of BRD4 in controlling TERT expression selectively in presence of cancer-associated promoter mutations, seems to suggest that inhibition of BRD4 by BETi could represent an alternative and more selective inhibition of telomerase. The gene discussed is TERT; the disease is cancer.